Top Story

FDA approves Xtoro for acute otitis externa

December 17, 2014

The FDA today announced the approval of Xtoro eardrops for the treatment of acute otitis externa caused by Pseudomonas aeruginosa and Staphylococcus aureus.

Xtoro (Alcon Laboratories) is the newest drug within the fluoroquinolone antimicrobial drug class approved by the FDA, according to a press release.

Meeting News Coverage

Hospital admissions for acute aortic dissection higher during flu season

December 17, 2014
CHICAGO — Monthly hospitalizations for acute aortic dissection were increased during the peak influenza season from November to March, according to data reported…
Karen Midthun FDA approvals

FDA approves plasma pathogen reduction system

December 17, 2014
The FDA has approved the first pathogen reduction system for use in plasma preparation, according to a press release. The Intercept Blood System (Cerus Corp.) for…

SomaGenics granted patents for small RNA platform technologies that inhibit HCV

December 17, 2014
The United States and European Patient Offices have collectively issued a total of four patents to SomaGenics spanning its small RNA platform technologies, according to…
In the Journals

Rheumatic hand manifestations observed in chronic HCV

December 17, 2014
Hepatitis C virus infection prompted hand manifestations among Egyptian patients, according to study data.  “Patients infected with HCV might develop at least…
More News Headlines »

Regimen Selection in HIV: Considering New Options to Optimize Outcomes

This activity is supported by an educational grant from Gilead Sciences Medical Affairs.

More than two decades into the antiretroviral therapy (ART) era, there are numerous options for HIV treatment. The goal…
More »
Meeting News Coverage Video
thumbnail for video 3911388507001

Student education, immunization requirements necessary to prevent outbreaks on college campuses

November 28, 2014
NEW YORK — James C. Turner, MD, executive director of the department of student health and the National Social…
More »

CRITICAL ISSUES IN HBV: Considerations in Optimizing HBV Treatment

This activity is supported by an educational grant from Gilead Sciences Medical Affairs.

Hepatitis B virus (HBV) infection is a global epidemic with a worldwide burden. Physicians must address the importance…
More »
morganatic-roan morganatic-roan